For the Inventor, By the Inventor

Enter assignee name

Pittsford, NY, United States of America

Srx Cardio, LLC

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 23.1

EPO Patents = 1

Forward Citations = 37

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Thomas E Barta (13 out of 47 patents)

Jonathan William Bourne (13 out of 16 patents)

Kyle D Monroe (11 out of 13 patents)

4. Michael Mark Muehlemann (11 out of 29 patents)

5. Anjali Pandey (8 out of 83 patents)

6. Simeon Bowers (8 out of 25 patents)

7. Jiang Zhu (1 out of 6 patents)

8. Eric T Baldwin (1 out of 4 patents)

9. Mark Karbarz (1 out of 4 patents)

10. Margaret Thompson Reece (1 out of 1 patent)

11. Vesa Nevalainen (1 out of 4 patents)

13 patents: Sort by Forward Citations

1. 12115154 - Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) (2024-10-15),

2. 11945782 - Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity (2024-04-02),

3. 11944619 - Phenylalanine small organic compounds to directly modulate PCSK9 protein activity (2024-04-02),

4. 11925637 - Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use (2024-03-12),

5. 11891369 - Compounds for binding proprotein convertase subtilisin/kexin type 9 (2024-02-06),

6. 11771710 - Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands (2023-10-03),

7. 11026957 - Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands (2021-06-08),

8. 10980801 - Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use (2021-04-20),

9. 10865185 - Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity (2020-12-15),

10. 10568882 - Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use (2020-02-25),

11. 10307433 - Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity (2019-06-04),

12. 10287317 - Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels (2019-05-14),

13. 10034892 - Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity (2018-07-31),

Company Overview

Srx Cardio, LLC is a medical technology company based in Pittsford, NY, specializing in innovative cardiovascular solutions. The organization focuses on developing advanced diagnostic and therapeutic devices aimed at improving patient outcomes in heart health. With a commitment to research and development, Srx Cardio leverages cutting-edge technology to address critical challenges in cardiovascular care, enhancing both clinical practices and patient experiences. Their work contributes significantly to the evolving landscape of medical devices and healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#4 in Pittsford, NY

#1,377 in New York

#23,863 in US

#45,104 in the World

Pittsford, NY, United States of America

Srx Cardio, LLC

Forward Citations = 37

11 inventors:

Thomas E Barta (13 out of 47 patents)

Jonathan William Bourne (13 out of 16 patents)

Kyle D Monroe (11 out of 13 patents)

4. Michael Mark Muehlemann (11 out of 29 patents)

5. Anjali Pandey (8 out of 83 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Srx Cardio, LLC. Retrieved from https://idiyas.com/company/srx-cardio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…